Pulmosmart G Pulmicaps

Pulmosmart G Pulmicaps is a triple combination inhalation therapy formulated for the long-term management of Chronic Obstructive Pulmonary Disease (COPD) and severe asthma. This advanced inhaler combines three key agents — Budesonide (an inhaled corticosteroid), Formoterol (a long-acting beta-2 agonist), and Glycopyrronium (a long-acting muscarinic antagonist) — providing comprehensive control over airway inflammation, bronchoconstriction, and mucus production.

Budesonide works by reducing airway inflammation and swelling, improving long-term lung health. Formoterol helps to relax airway muscles, ensuring smooth airflow and quick relief from breathlessness, while Glycopyrronium prevents airway tightening by blocking the muscarinic receptors responsible for bronchospasm.